Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate specific antigen is metabolized in the liver

A H Agha1, E Schechter, J B Roy

  • 1Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, USA.

The Journal of Urology
|April 1, 1996
PubMed
Summary

Prostate specific antigen (PSA) is released from the prostate. The liver, not the kidneys or lungs, is the primary site for PSA metabolism, as shown by decreased PSA levels across the hepatic circulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antevenene in the treatment of black-water fever.

Indian medical journal·2010
Same author

Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.

Journal of cardiovascular pharmacology·2008
Same author

Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.

Endocrine-related cancer·2006
Same author

5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation.

Prostate cancer and prostatic diseases·2004
Same author

Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients.

Atherosclerosis·2001
Same author

Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts.

American heart journal·2000

Area of Science:

  • Urology
  • Biochemistry
  • Medical Research

Background:

  • Prostate specific antigen (PSA) is a key biomarker in prostate health.
  • Understanding the metabolic fate of PSA is crucial for interpreting its clinical significance.
  • Previous studies have not definitively identified the primary site of PSA metabolism.

Purpose of the Study:

  • To determine the primary site of prostate specific antigen (PSA) metabolism in vivo.
  • To investigate the role of hepatic, renal, and pulmonary circulation in PSA clearance.

Main Methods:

  • Prospective study involving 12 male patients undergoing cardiac catheterization.
  • Selective blood sampling from various vascular sites including inferior vena cava (infra- and supra-hepatic), renal vein, superior vena cava, pulmonary artery, and femoral artery.

Related Experiment Videos

  • Analysis of PSA concentration gradients across different circulatory systems using paired Student t tests.

    • Main Results:

    • A statistically significant decrease in PSA concentration was observed across the hepatic circulation (8.3% reduction, p=0.04).
    • No significant decrease in PSA was found across the renal circulation.
    • A statistically insignificant decrease in PSA was noted across the pulmonary circulation.
    • A significant increase in PSA concentration was observed across the pelvic circulation (16.3% increase, p=0.003), confirming prostatic release.

    Conclusions:

    • Prostate specific antigen (PSA) is released from the prostate gland.
    • The liver is the most likely site of PSA metabolism.
    • The kidneys and lungs play a minimal role in the elimination of PSA.